← Eichor
Condition: Hypofractionation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hypofractionation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinom
Phase 2 · 1 location(s) · Anhui Provincial Hospital · NCT07188103Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06389422Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer
NA · 1 location(s) · Siriraj Hospital · NCT07595224Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07691619The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer
Phase 2 · 1 location(s) · Fudan University · NCT05628038One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer
NA · 1 location(s) · Tata Medical Center · NCT03788213Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Phase 2 · 1 location(s) · Mayo Clinic · NCT06635980A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer.
Phase 2 · 1 location(s) · Shanghai Proton and Heavy Ion Center · NCT06677879A Study Of Moderately Hypo-Fractionated External-beam Radiotherapy With Concurrent Chemotherapy and High Dose Rate Brach
NA · 1 location(s) · Ain Shams University · NCT07343531Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NA · 2 location(s) · University of California, San Francisco · NCT04221893Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07447570Adjuvant Hypofractionated Radiotherapy for Prostate Cancer
NA · 1 location(s) · Changhai Hospital · NCT06335693Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
Phase 1/Phase 2 · 1 location(s) · Coordination Pharmaceuticals, Inc. · NCT05838729HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).
NA · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT04472845Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
NA · 19 location(s) · University Health Network, Toronto · NCT05592938A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT
Phase N/A · 2 location(s) · Chang Gung Memorial Hospital · NCT04805255Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Pati
Phase 2 · 1 location(s) · Samsung Medical Center · NCT064617935 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics
NA · 1 location(s) · IRCCS San Raffaele · NCT07020780SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
Phase 3 · 6 location(s) · Mayo Clinic · NCT06205316Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial
Phase 2 · 3 location(s) · Brigham and Women's Hospital · NCT06835803Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma
Phase 2 · 3 location(s) · Abramson Cancer Center at Penn Medicine · NCT03646617Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
Phase N/A · 1 location(s) · University of Oklahoma · NCT07014618Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes
Phase N/A · 1 location(s) · European Institute of Oncology · NCT06321653Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC
Phase 2 · 1 location(s) · Peking University Cancer Hospital & Institute · NCT06849167A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Th
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07358676LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
NA · 5 location(s) · University of Maryland, Baltimore · NCT04699773Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)
NA · 1 location(s) · Samsung Medical Center · NCT05453682Advanced Proton Therapy Approaches: a Multicenter High-quality Data Registry
Phase N/A · 1 location(s) · European Institute of Oncology · NCT05860361Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base
NA · 1 location(s) · Quironsalud · NCT05861245MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer
Phase 2 · 1 location(s) · University of Vermont Medical Center · NCT06998342
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.